Two B‐cell subpopulations (IgA+IGLC2+ plasma cells and cycling B cells) were found to have opposite effects on CRC prognosis, as the former correlated with poor patient survival, whereas the latter correlated with favorable patient survival. The gene discussed is IGLC2; the disease is colorectal carcinoma.